 | EAL | 表記: | 1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE | 組成式: | C18 H24 N2 O5 | SMILES: | O=C(O)C2N(C(=O)C(NC(C(=O)O)CCc1ccccc1)C)CCC2 | InChi: | InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1 | 別名: | ENALAPRILAT INHIBITOR | 定義日: | 2004-03-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline |
|
 | EAX | 表記: | (2R,3R)-2,3,4-trihydroxybutanoic acid | 組成式: | C4 H8 O5 | SMILES: | O=C(O)C(O)C(O)CO | InChi: | InChI=1S/C4H8O5/c5-1-2(6)3(7)4(8)9/h2-3,5-7H,1H2,(H,8,9)/t2-,3-/m1/s1 | 別名: | erythronic acid | 定義日: | 2014-04-07 | 最終更新日: | 2021-03-01 | 公開日: | 2014-05-07 | 識別子(ID): | (2R,3R)-2,3,4-trihydroxybutanoic acid |
|
 | EB4 | 表記: | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo-1,5,9-trioxacyclododecane-3,7,11-triyl]tris(2,3-dihydroxybenzamide) | 組成式: | C30 H27 N3 O15 | SMILES: | O=C2OCC(C(=O)OCC(C(=O)OCC2NC(=O)c1cccc(O)c1O)NC(=O)c3cccc(O)c3O)NC(=O)c4cccc(O)c4O | InChi: | InChI=1S/C30H27N3O15/c34-19-7-1-4-13(22(19)37)25(40)31-16-10-46-29(44)18(33-27(42)15-6-3-9-21(36)24(15)39)12-48-30(45)17(11-47-28(16)43)32-26(41)14-5-2-8-20(35)23(14)38/h1-9,16-18,34-39H,10-12H2,(H,31,40)(H,32,41)(H,33,42)/t16-,17-,18-/m0/s1 | 別名: | Enterobactin | 定義日: | 2008-04-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo-1,5,9-trioxacyclododecane-3,7,11-triyl]tris(2,3-dihydroxybenzamide) |
|
 | ECB | 表記: | 1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | 組成式: | C23 H38 O4 | SMILES: | CCCCCC=C/CC=C/C[C@H]=[C@H]C[C@H]=[C@H]CCCC(=O)OC(CO)CO | InChi: | InChI=1S/C23H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)27-22(20-24)21-25/h6-7,9-10,12-13,15-16,22,24-25H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15- | 別名: | 2-arachidonoylglycerol | 定義日: | 2017-12-07 | 最終更新日: | 2021-03-01 | 公開日: | 2018-12-12 | 識別子(ID): | 1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate |
|
 | ECL | 表記: | 1-[(2R)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole | 組成式: | C18 H15 Cl3 N2 O | SMILES: | Clc1ccc(c(Cl)c1)C(OCc2ccc(Cl)cc2)Cn3ccnc3 | InChi: | InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2/t18-/m0/s1 | 別名: | R-Econazole | 定義日: | 2010-02-16 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1-[(2R)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole |
|
 | EDH | 表記: | N~1~-(1-propyl-1,3-dihydro-2H-benzimidazol-2-ylidene)benzene-1,3-dicarboxamide | 組成式: | C18 H18 N4 O2 | SMILES: | C(c3cccc(C(=O)/N=C1Nc2c(N1CCC)cccc2)c3)(=O)N | InChi: | InChI=1S/C18H18N4O2/c1-2-10-22-15-9-4-3-8-14(15)20-18(22)21-17(24)13-7-5-6-12(11-13)16(19)23/h3-9,11H,2,10H2,1H3,(H2,19,23)(H,20,21,24) | 別名: | EDHS-206 | 定義日: | 2017-05-17 | 最終更新日: | 2021-03-01 | 公開日: | 2017-08-30 | 識別子(ID): | N~1~-(1-propyl-1,3-dihydro-2H-benzimidazol-2-ylidene)benzene-1,3-dicarboxamide |
|
 | EDO | 表記: | 1,2-ETHANEDIOL | 組成式: | C2 H6 O2 | SMILES: | OCCO | InChi: | InChI=1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2 | 別名: | ETHYLENE GLYCOL | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | ethane-1,2-diol |
|
 | EDP | 表記: | 5-ethyl-5-[(2R)-pentan-2-yl]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | 組成式: | C11 H18 N2 O2 S | SMILES: | O=C1NC(=S)NC(=O)C1(C(C)CCC)CC | InChi: | InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)/t7-/m1/s1 | 別名: | Thiopental | 定義日: | 2011-04-05 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5-ethyl-5-[(2R)-pentan-2-yl]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione |
|
 | EDV | 表記: | 1-(2-deoxy-2-methyl-beta-D-arabinofuranosyl)-5-ethynylpyrimidine-2,4(1H,3H)-dione | 組成式: | C12 H14 N2 O5 | SMILES: | O=C1NC(=O)N(C=C1C#C)C2OC(C(O)C2C)CO | InChi: | InChI=1S/C12H14N2O5/c1-3-7-4-14(12(18)13-10(7)17)11-6(2)9(16)8(5-15)19-11/h1,4,6,8-9,11,15-16H,5H2,2H3,(H,13,17,18)/t6-,8+,9-,11+/m0/s1 | 別名: | (2'S)-2'-DEOXY-2'-METHYL-5-ETHYNYLURIDINE | 定義日: | 2014-02-12 | 最終更新日: | 2021-03-01 | 公開日: | 2014-08-13 | 識別子(ID): | 1-(2-deoxy-2-methyl-beta-D-arabinofuranosyl)-5-ethynylpyrimidine-2,4(1H,3H)-dione |
|
 | EE1 | 表記: | (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid | 組成式: | C26 H34 N7 O22 P3 | SMILES: | NC(=O)C1=CN(C=C[CH]1[CH](CC(O)=O)C(=O)C(O)=O)[CH]2O[CH](CO[P](O)(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O[P](O)(O)=O)[CH]3O)n4cnc5c(N)ncnc45)[CH](O)[CH]2O | InChi: | InChI=1S/C26H34N7O22P3/c27-21-15-23(30-7-29-21)33(8-31-15)25-20(54-56(43,44)45)18(38)13(53-25)6-51-58(48,49)55-57(46,47)50-5-12-17(37)19(39)24(52-12)32-2-1-9(11(4-32)22(28)40)10(3-14(34)35)16(36)26(41)42/h1-2,4,7-10,12-13,17-20,24-25,37-39H,3,5-6H2,(H2,28,40)(H,34,35)(H,41,42)(H,46,47)(H,48,49)(H2,27,29,30)(H2,43,44,45)/t9-,10-,12+,13+,17+,18+,19+,20+,24+,25+/m0/s1 | 別名: | NADPH with ketoglutarate adduct | 定義日: | 2018-01-02 | 最終更新日: | 2021-03-01 | 公開日: | 2018-02-07 | 識別子(ID): | (3~{S})-3-[(4~{S})-3-aminocarbonyl-1-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]-4~{H}-pyridin-4-yl]-2-oxidanylidene-pentanedioic acid |
|
 | EEM | 表記: | [(3S)-3-amino-4-hydroxy-4-oxo-butyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl]-methyl-selanium | 組成式: | C15 H23 N6 O5 Se | SMILES: | O=C(O)C(N)CC[Se+](C)CC3OC(n2cnc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C15H22N6O5Se/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27-/m0/s1 | 別名: | Se-ADENOSYLSELENOMETHIONINE | 定義日: | 2008-09-03 | 最終更新日: | 2021-03-01 | 識別子(ID): | [(3S)-3-amino-3-carboxypropyl]{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl}methylselenonium (non-preferred name) |
|
 | EG8 | 表記: | N-{2-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]ethyl}-3-(pyridin-3-yl)propan-1-amine | 組成式: | C17 H20 N6 | SMILES: | n1ccc(nc1n2ccnc2)CCNCCCc3cccnc3 | InChi: | InChI=1S/C17H20N6/c1(3-15-4-2-8-19-13-15)7-18-9-5-16-6-10-21-17(22-16)23-12-11-20-14-23/h2,4,6,8,10-14,18H,1,3,5,7,9H2 | 別名: | N-2-(2-(1H-imidazol-1-yl)pyrimidin-4-yl)ethyl-3-(pyridin-3-yl)propan-1-amine | 定義日: | 2014-10-21 | 最終更新日: | 2021-03-01 | 公開日: | 2014-12-24 | 識別子(ID): | N-{2-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]ethyl}-3-(pyridin-3-yl)propan-1-amine |
|
 | EGR | 表記: | ethyl 3,4,5-trihydroxybenzoate | 組成式: | C9 H10 O5 | SMILES: | O=C(OCC)c1cc(O)c(O)c(O)c1 | InChi: | InChI=1S/C9H10O5/c1-2-14-9(13)5-3-6(10)8(12)7(11)4-5/h3-4,10-12H,2H2,1H3 | 別名: | ethyl gallate | 定義日: | 2013-02-14 | 最終更新日: | 2021-03-01 | 公開日: | 2013-05-22 | 識別子(ID): | ethyl 3,4,5-trihydroxybenzoate |
|
 | EGT | 表記: | 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL | 組成式: | C15 H14 O7 | SMILES: | Oc1cc(cc(O)c1O)C3Oc2cc(O)cc(O)c2CC3O | InChi: | InChI=1S/C15H14O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-4,12,15-21H,5H2/t12-,15-/m1/s1 | 別名: | EPIGALLOCATECHIN | 定義日: | 2001-08-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol |
|
 | EHD | 表記: | 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE | 組成式: | C20 H16 N2 O4 | SMILES: | O=C1N4C(=CC2=C1COC(=O)C2(O)CC)c3nc5c(cc3C4)cccc5 | InChi: | InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1 | 別名: | CAMPTOTHECIN | 定義日: | 2004-06-09 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
|
 | EIT | 表記: | ((3R,4R,5R)-4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)-3-HYDROXY-5-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-TETRAHYDROFURAN-2-YL)METHYL DIHYDROGEN PHOSPHATE | 組成式: | C15 H21 N4 O9 P | SMILES: | O=C1NC(=O)N(C=C1C)C3OC(C(O)C3OCCn2ccnc2)COP(=O)(O)O | InChi: | InChI=1S/C15H21N4O9P/c1-9-6-19(15(22)17-13(9)21)14-12(26-5-4-18-3-2-16-8-18)11(20)10(28-14)7-27-29(23,24)25/h2-3,6,8,10-12,14,20H,4-5,7H2,1H3,(H,17,21,22)(H2,23,24,25)/t10-,11-,12-,14-/m1/s1 | 別名: | 2'-O-[1-ETHYL-1H-IMIDAZOL)] THYMIDINE-5'-MONOPHOSPHATE | 定義日: | 2004-12-16 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2'-O-[2-(1H-imidazol-1-yl)ethyl]-5-methyluridine 5'-(dihydrogen phosphate) |
|
 | EJ4 | 表記: | (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol | 組成式: | C26 H26 N2 O3 | SMILES: | Oc4c3OC7c2c(c1ccccc1n2)CC6(O)C5N(CCC67c3c(cc4)C5)CC8CC8 | InChi: | InChI=1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1 | 別名: | Naltrindole | 定義日: | 2012-04-13 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4bS,8R,8aS,14bR)-7-(cyclopropylmethyl)-5,6,7,8,14,14b-hexahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazole-1,8a(9H)-diol |
|
 | ELD | 表記: | (9E)-OCTADEC-9-ENAMIDE | 組成式: | C18 H35 N O | SMILES: | O=C(N)CCCCCCCC=C/CCCCCCCC | InChi: | InChI=1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H2,19,20) | 別名: | ELAIDOYLAMIDE | 定義日: | 2003-12-02 | 最終更新日: | 2021-03-01 | 識別子(ID): | (9Z)-octadec-9-enamide |
|
 | EML | 表記: | 2-{ethyl[(5-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}isothiazol-3-yl)methyl]amino}-2-methylpropan-1-ol | 組成式: | C20 H26 N8 O S | SMILES: | n1ncc(c1)c2cnc3n2cc(nc3Nc4snc(c4)CN(CC)C(C)(C)CO)C | InChi: | InChI=1S/C20H26N8OS/c1-5-27(20(3,4)12-29)11-15-6-17(30-26-15)25-18-19-21-9-16(14-7-22-23-8-14)28(19)10-13(2)24-18/h6-10,29H,5,11-12H2,1-4H3,(H,22,23)(H,24,25) | 別名: | SCH 1473759 | 定義日: | 2010-05-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2-{ethyl[(5-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}-1,2-thiazol-3-yl)methyl]amino}-2-methylpropan-1-ol |
|
 | EMU | 表記: | N-BENZYL-9H-PURIN-6-AMINE | 組成式: | C12 H11 N5 | SMILES: | n2c1c(ncn1)c(nc2)NCc3ccccc3 | InChi: | InChI=1S/C12H11N5/c1-2-4-9(5-3-1)6-13-11-10-12(15-7-14-10)17-8-16-11/h1-5,7-8H,6H2,(H2,13,14,15,16,17) | 別名: | BENZYLAMINOPURINE | 定義日: | 2006-10-19 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-benzyl-9H-purin-6-amine |
|
 | EOL | 表記: | 2-methoxy-4-(prop-2-en-1-yl)phenol | 組成式: | C10 H12 O2 | SMILES: | Oc1ccc(cc1OC)CC=C | InChi: | InChI=1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3 | 別名: | eugenol | 定義日: | 2011-05-17 | 最終更新日: | 2021-03-01 | 識別子(ID): | 2-methoxy-4-(prop-2-en-1-yl)phenol |
|
 | EP2 | 表記: | methyl N-[(2S)-4-{[(1S)-1-{[(2S)-2-carboxypyrrolidin-1-yl]carbonyl}-3-methylbutyl]amino}-2-hydroxy-4-oxobutanoyl]-L-leucylglycylglycinate | 組成式: | C26 H41 N5 O10 | SMILES: | O=C(NC(C(=O)N1C(C(=O)O)CCC1)CC(C)C)C2OC2C(=O)NC(C(=O)NCC(=O)NCC(=O)OC)CC(C)C | InChi: | InChI=1S/C26H41N5O10/c1-13(2)9-15(22(34)28-11-18(32)27-12-19(33)40-5)29-23(35)20-21(41-20)24(36)30-16(10-14(3)4)25(37)31-8-6-7-17(31)26(38)39/h13-17,20-21H,6-12H2,1-5H3,(H,27,32)(H,28,34)(H,29,35)(H,30,36)(H,38,39)/t15-,16-,17-,20-,21-/m0/s1 | 別名: | NS-134 | 定義日: | 2008-03-25 | 最終更新日: | 2021-03-01 | 識別子(ID): | methyl N-{[(2S,3S)-3-{[(1S)-1-{[(2S)-2-carboxypyrrolidin-1-yl]carbonyl}-3-methylbutyl]carbamoyl}oxiran-2-yl]carbonyl}-L-leucylglycylglycinate |
|
 | EPB | 表記: | 7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[1-METHYL-2-(2-METHYL-THIAZOL-4-YL)VINYL]-4,17-DIOXABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE | 組成式: | C27 H41 N O6 S | SMILES: | O=C1C(C)C(O)C(C)CCCC3(OC3CC(OC(=O)CC(O)C1(C)C)/C(=C/c2nc(sc2)C)C)C | InChi: | InChI=1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1 | 別名: | EPOTHILONE B | 定義日: | 2003-08-07 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione |
|
 | EPJ | 表記: | EPIBATIDINE | 組成式: | C11 H13 Cl N2 | SMILES: | Clc1ncc(cc1)C3CC2NC3CC2 | InChi: | InChI=1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2/t8-,9+,10+/m0/s1 | 別名: | (2R)-2-(6-CHLOROPYRIDIN-3-YL)-7-AZABICYCLO[2.2.1]HEPTANE | 定義日: | 2003-08-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1R,2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane |
|
 | EPR | 表記: | {5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid | 組成式: | C15 H13 N O3 S2 | SMILES: | S=C1S/C(C(=O)N1CC(=O)O)=C/C(=C/c2ccccc2)C | InChi: | InChI=1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8? | 別名: | Epalrestat | 定義日: | 2013-03-25 | 最終更新日: | 2021-03-01 | 公開日: | 2013-10-23 | 識別子(ID): | {(5E)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}acetic acid |
|